Suppr超能文献

基于鲁米诺@AuPt/ZIF-67 和 MnO@CNTs 的双猝灭 ECL 免疫传感器用于超灵敏检测视黄醇结合蛋白 4

A dual-quenched ECL immunosensor for ultrasensitive detection of retinol binding protein 4 based on luminol@AuPt/ZIF-67 and MnO@CNTs.

机构信息

Medical Examination Centre, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

出版信息

J Nanobiotechnology. 2021 Sep 8;19(1):272. doi: 10.1186/s12951-021-01020-1.

Abstract

BACKGROUND

Retinol binding protein 4 (RBP4) has been regarded as an important serological biomarker for type 2 diabetes mellitus (T2DM). Hence, the construction of a highly sensitive detection method for RBP4 is the key to early prevention and multidisciplinary intervention of T2DM. In this work, a dual-quenched electrochemiluminescence (ECL) immunosensor has been fabricated for ultrasensitive detection of RBP4 by combining zeolitic imidazolate framework-67/AuPt-supported luminol (luminol@AuPt/ZIF-67) with MnO nanosheets-grown on carbon nanotubes (MnO@CNTs).

RESULTS

AuPt/ZIF-67 hybrids with high-efficiency peroxidase-like activity could provide multipoint binding sites for luminol and antibodies and significantly boost the amplified initial signal of the ECL immunosensor. Upon glutathione/HO coreactants system, MnO@CNTs composites could quench the initial signal by inhibiting mimic peroxidase activity of luminol@AuPt/ZIF-67. Moreover, the absorption spectrum of the MnO@CNTs composites completely overlaps with the emission spectrum of luminol, which can further reduce initial signal by ECL resonance energy transfer (ECL-RET).

CONCLUSIONS

Benefiting from the above-mentioned properties, the designed immunoassay sensitivity exhibited excellent sensitivity and relative stability for RBP4 detection range from 0.0001 to 100 ng mL with a low detection limit of 43 fg mL. Therefore, our ECL immunosensor provides an alternative assaying strategy for early diagnosis of T2DM.

摘要

背景

视黄醇结合蛋白 4(RBP4)已被视为 2 型糖尿病(T2DM)的重要血清生物标志物。因此,构建一种高灵敏度的 RBP4 检测方法是 T2DM 早期预防和多学科干预的关键。在这项工作中,通过将沸石咪唑酯骨架-67/AuPt 负载的鲁米诺(luminol@AuPt/ZIF-67)与负载在碳纳米管上的 MnO 纳米片(MnO@CNTs)相结合,构建了一种用于超灵敏检测 RBP4 的双猝灭电化学发光(ECL)免疫传感器。

结果

具有高效过氧化物酶样活性的 AuPt/ZIF-67 混合物可为鲁米诺和抗体提供多点结合位点,并显著提高 ECL 免疫传感器的初始信号放大。在谷胱甘肽/HO 反应剂体系中,MnO@CNTs 复合材料可以通过抑制 luminol@AuPt/ZIF-67 的模拟过氧化物酶活性来猝灭初始信号。此外,MnO@CNTs 复合材料的吸收光谱与鲁米诺的发射光谱完全重叠,这可以通过电化学共振能量转移(ECL-RET)进一步降低初始信号。

结论

得益于上述特性,所设计的免疫分析具有出色的灵敏度,可用于检测 0.0001 至 100ng/mL 范围内的 RBP4,检测限低至 43fg/mL。因此,我们的 ECL 免疫传感器为 T2DM 的早期诊断提供了一种替代的分析策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a3c/8425071/11a5cba8855c/12951_2021_1020_Sch1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验